On the face of it, selling to the NHS is the same regardless of what your product is, whether that be within devices or pharmaceuticals. However, on closer inspection there are major differences between selling a drug to selling a device.
In the news this week: the CQC publishes its 2019 ‘State of Care’ report, the government proposes a new patient safety regulator, an inexpensive drug could ‘save thousands of lives a year’ from head injuries, and could British HIV-positive patients living in Spain lose their healthcare post-Brexit?
Top jobs for April feature marketing positions including Senior Brand Manager and Senior Marketing Manager, as well as Sales Force Effectiveness and Business Insights Manager, and Study Start Up Delivery Lead. Find out more -
The UK as a global leader in antimicrobial resistance, updates to prescribing information in a no-deal Brexit, an improved pharma sales outlook for J&J and thoughts on ABPI feedback. Top pharma headlines this week!
E-learning tools to help health professionals prevent illness, a nursing apprenticeship to address NHS skills gaps, and EU healthcare professionals to still practise in the UK post-Brexit.
Top headlines across the medical devices sector this week include what exporters need to know about the CE Mark post-Brexit, the wearable tech errors worrying well people, and warnings of inaccessibility of devices in a no-deal Brexit.
The Duchess of Cambridge and Game of Thrones’s Emilia Clarke get behind the Nursing Now campaign, legislation will protect Scottish residents accessing cross-border European healthcare in a no-deal Brexit, and the UK’s top gynaecologist leads an effort to revolutionise health services for women.
It’s come around again! Top jobs from Star this month include some exciting Theatre/Surgical Sales Specialists across multiple territories, Key Account Managers, Hospital Sales Executives, Product Managers, Head of Private Sector, and Senior Marketing Manager positions. Find out more -
In a tumultuous week for Brexit negotiations, medical devices headlines include MedTech Europe writing to EU commissioners on dangers to the industry, and a report on 10 ways we could be affected by no-deal including access to medicines. Other stories include the FDA on regulating AI in medical technology.
New biosimilar launches in the UK, campaigners say Donald Trump’s Brexit trade plan will damage the NHS, and fake medications are “easily” bought on Facebook. These are some of the top stories making headlines across pharma this week!